Isotis Nv - N.ISO- Profile

ISOTIS NV. The Group's principal activities are the research of regenerative and substitution medicine through tissue engineering. The Group operates research laboratories and production facilities for the development of tissue engineered products to replace human tissues. These technologies are based on the generation of replicas of the human tissue by using patients' own cells. Government Grants accounted for 90% of 2001 revenues, Product Sales, 8% and Research Contracts, 2%. Government Grants accounted for 90% of 2001 revenues, Product Sales, 8% and Research Contracts, 2%